EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

Folasade Adelekan-Popoola, Shakirat Gold-Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A Balogun iD

Therapeutic Apheresis and Dialysis · 2026-12 · 30 (6) · 865-871

DOI: 10.1002/1744-9987.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 28.06.2026. Verfasst von Folasade Adelekan-Popoola und 4 weiteren Autor:innen. Beteiligte Einrichtung: Next Hematology Medicare, Lagos, Nigeria. Hauptthemen laut MEDLINE: Blood Component Removal. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse. This study describes the 5‐year operational experience of building and sustaining an Apheresis Medicine program at Next Hematology Medicare, a private hematology center in Lagos, Nigeria, including the challenges encountered, solutions implemented, and clinical outcomes achieved.

Methods

A retrospective review of all apheresis procedures performed between May 2020 and December 2025 was conducted. Therapeutic apheresis procedures included automated red cell exchange transfusion (RCE), therapeutic plasma exchange (TPE) and leukocytapheresis. Donor apheresis procedures comprised single‐donor apheresis platelet collections for transfusion and stem cell collection (SCC) by donors. Data on patient demographics, clinical indications, procedural outcomes, and geographic distribution of platelet delivery were collected and analyzed.

Results

A total of 2405 apheresis procedures were performed over the 5‐year period. Donor apheresis platelet (AP) collection was the most frequently performed procedure ( n = 1772; 73.7%), followed by RCE ( n = 617; 25.7%) as the most common therapeutic apheresis modality. TPE accounted for 12 procedures ( n = 12; 0.5%), while leukocytapheresis ( n = 2; < 0.1%) and SCC ( n = 1; < 0.1%) were performed infrequently. For AP, Sepsis/DIC was the leading transfusion indication ( n = 968; 54.6%). RCE was performed predominantly for patients with sickle cell anemia (SCA), with intractable recurrent vaso‐occlusive crises (VOC) being the most common indication ( n = 382; 61.9%). RCE significantly reduced hemoglobin S (HbS%) from 93.13% ± 12.4% to 18.74% ± 4.2% ( p < 0.001) and improved hematocrit from 16.34% ± 3.5% to 26.01% ± 4.2% ( p < 0.001). TPE was primarily indicated for neurological and transplant‐related conditions. Apheresis platelets were distributed nationally across all six geopolitical zones and internationally.

Conclusion

A fully functional Apheresis Medicine program can be successfully established and sustained in a resource‐constrained low‐ and middle‐income country (LMIC) setting, delivering outcomes comparable to high‐income country benchmarks. RCE showed significant hematological benefits for patients with SCA, and donor apheresis platelet delivery extended care across all Nigerian geopolitical zones. The operational framework described here, addressing funding, infrastructure, staffing, licensing, and blood safety, provides a possibly replicable model for Apheresis Medicine program development across sub‐Saharan Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Component RemovalHumansNigeriaRetrospective StudiesFemaleMalePlasma ExchangeResource-Limited SettingsAdultMiddle AgedAdolescentChildLeukapheresisChild, PreschoolYoung Adult

Stichwörter der Autor:innen

Nigeriaapheresisblood component removalsickle cell anemiatherapeutic plasma exchange

Autor:innen und Institutionen

  • Next Hematology Medicare, Lagos, Nigeria.
  • Brookdale University Hospital and Medical Center, Brooklyn, New York, USA.
  • Division of Clinical Hematology, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria.
  • Division of Nephrology, University of Virginia, Charlottesville, Virginia, USA.
  • Department of Pathology, University of Virginia, Charlottesville, Virginia, USA.

ORCID-Profile: Rasheed A Balogun

Zitieren

APA

Adelekan-Popoola, F., Gold-Olufadi, S., Kalejaiye, O. O., Ogala, A., & Balogun, R. A. (2026). Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria. Therapeutic Apheresis and Dialysis, 30(6), 865-871. https://doi.org/10.1002/1744-9987.70176

Vancouver

Adelekan-Popoola F, Gold-Olufadi S, Kalejaiye OO, Ogala A, Balogun RA. Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria. Therapeutic Apheresis and Dialysis. 2026;30(6):865-871. doi:10.1002/1744-9987.70176

BibTeX
@article{AdelekanPopoola2026,
  author = {Adelekan-Popoola, Folasade and Gold-Olufadi, Shakirat and Kalejaiye, Olufunto Olufela and Ogala, Abdullateef and Balogun, Rasheed A},
  title = {Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {865--871},
  doi = {10.1002/1744-9987.70176}
}
Kostenlos starten →